EMEA (Europe, Middle East and Africa) Naloxone Market Report 2018

January 2018 | 101 pages | ID: ED0EEBD7048EN
QYResearch

Abstracts

In this report, the EMEA Naloxone market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Naloxone for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Naloxone market competition by top manufacturers/players, with Naloxone sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• ADAPT Pharma
• Amphastar Pharmaceuticals
• Pfizer
• kaleo
• Sandoz
• Amneal Pharmaceuticals
• West Ward Pharmaceuticals
• Mylan

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Spray forms
• Injectable forms

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Opioid overdose
• Preventing opioid abuse

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Naloxone Market Report 2017

1 NALOXONE OVERVIEW

1.1 Product Overview and Scope of Naloxone
1.2 Classification of Naloxone
  1.2.1 EMEA Naloxone Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Naloxone Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Spray forms
  1.2.4 Injectable forms
1.3 EMEA Naloxone Market by Application/End Users
  1.3.1 EMEA Naloxone Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Opioid overdose
  1.3.3 Preventing opioid abuse
1.4 EMEA Naloxone Market by Region
  1.4.1 EMEA Naloxone Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Naloxone (2012-2022)
  1.5.1 EMEA Naloxone Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Naloxone Revenue and Growth Rate (2012-2022)

2 EMEA NALOXONE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Naloxone Market Competition by Players/Manufacturers
  2.1.1 EMEA Naloxone Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Naloxone Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Naloxone Sale Price by Players (2012-2017)
2.2 EMEA Naloxone (Volume and Value) by Type/Product Category
  2.2.1 EMEA Naloxone Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Naloxone Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Naloxone Sale Price by Type (2012-2017)
2.3 EMEA Naloxone (Volume) by Application
2.4 EMEA Naloxone (Volume and Value) by Region
  2.4.1 EMEA Naloxone Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Naloxone Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Naloxone Sales Price by Region (2012-2017)

3 EUROPE NALOXONE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Naloxone Sales and Value (2012-2017)
  3.1.1 Europe Naloxone Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Naloxone Revenue and Growth Rate (2012-2017)
3.2 Europe Naloxone Sales and Market Share by Type
3.3 Europe Naloxone Sales and Market Share by Application
3.4 Europe Naloxone Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Naloxone Sales Volume by Countries (2012-2017)
  3.4.2 Europe Naloxone Revenue by Countries (2012-2017)
  3.4.3 Germany Naloxone Sales and Growth Rate (2012-2017)
  3.4.4 France Naloxone Sales and Growth Rate (2012-2017)
  3.4.5 UK Naloxone Sales and Growth Rate (2012-2017)
  3.4.6 Russia Naloxone Sales and Growth Rate (2012-2017)
  3.4.7 Italy Naloxone Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Naloxone Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NALOXONE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Naloxone Sales and Value (2012-2017)
  4.1.1 Middle East Naloxone Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Naloxone Revenue and Growth Rate (2012-2017)
4.2 Middle East Naloxone Sales and Market Share by Type
4.3 Middle East Naloxone Sales and Market Share by Application
4.4 Middle East Naloxone Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Naloxone Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Naloxone Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Naloxone Sales and Growth Rate (2012-2017)
  4.4.4 Israel Naloxone Sales and Growth Rate (2012-2017)
  4.4.5 UAE Naloxone Sales and Growth Rate (2012-2017)
  4.4.6 Iran Naloxone Sales and Growth Rate (2012-2017)

5 AFRICA NALOXONE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Naloxone Sales and Value (2012-2017)
  5.1.1 Africa Naloxone Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Naloxone Revenue and Growth Rate (2012-2017)
5.2 Africa Naloxone Sales and Market Share by Type
5.3 Africa Naloxone Sales and Market Share by Application
5.4 Africa Naloxone Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Naloxone Sales Volume by Countries (2012-2017)
  5.4.2 Africa Naloxone Revenue by Countries (2012-2017)
  5.4.3 South Africa Naloxone Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Naloxone Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Naloxone Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Naloxone Sales and Growth Rate (2012-2017)

6 EMEA NALOXONE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 ADAPT Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Naloxone Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ADAPT Pharma Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amphastar Pharmaceuticals
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Naloxone Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amphastar Pharmaceuticals Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Naloxone Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 kaleo
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Naloxone Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 kaleo Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sandoz
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Naloxone Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sandoz Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Amneal Pharmaceuticals
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Naloxone Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Amneal Pharmaceuticals Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 West Ward Pharmaceuticals
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Naloxone Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 West Ward Pharmaceuticals Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Mylan
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Naloxone Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mylan Naloxone Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 NALOXONE MANUFACTURING COST ANALYSIS

7.1 Naloxone Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Naloxone

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Naloxone Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Naloxone Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NALOXONE MARKET FORECAST (2017-2022)

11.1 EMEA Naloxone Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Naloxone Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Naloxone Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Naloxone Price and Trend Forecast (2017-2022)
11.2 EMEA Naloxone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Naloxone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Naloxone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Naloxone Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Naloxone Sales Forecast by Type (2017-2022)
11.7 EMEA Naloxone Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Naloxone
Figure EMEA Naloxone Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Naloxone Sales Volume Market Share by Type (Product Category) in 2016
Figure Spray forms Product Picture
Figure Injectable forms Product Picture
Figure EMEA Naloxone Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Naloxone by Application in 2016
Figure Opioid overdose Examples
Table Key Downstream Customer in Opioid overdose
Figure Preventing opioid abuse Examples
Table Key Downstream Customer in Preventing opioid abuse
Figure EMEA Naloxone Market Size (Million USD) by Region (2012-2022)
Figure Europe Naloxone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Naloxone Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Naloxone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Naloxone Revenue (Million USD) Status and Forecast by Countries
Figure Africa Naloxone Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Naloxone Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Naloxone Sales Volume and Growth Rate (2012-2022)
Figure EMEA Naloxone Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Naloxone Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Naloxone Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Naloxone Sales Share by Players (2012-2017)
Figure 2016 Naloxone Sales Share by Players
Figure 2017 Naloxone Sales Share by Players
Figure EMEA Naloxone Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Naloxone Revenue (Million USD) by Players (2012-2017)
Table EMEA Naloxone Revenue Share by Players (2012-2017)
Table 2016 EMEA Naloxone Revenue Share by Players
Table 2017 EMEA Naloxone Revenue Share by Players
Table EMEA Naloxone Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Naloxone Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Naloxone Sales Share by Type (2012-2017)
Figure Sales Market Share of Naloxone by Type (2012-2017)
Figure EMEA Naloxone Sales Market Share by Type (2012-2017)
Table EMEA Naloxone Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Naloxone Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Naloxone by Type in 2016
Table EMEA Naloxone Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Naloxone Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Naloxone Sales Share by Application (2012-2017)
Figure Sales Market Share of Naloxone by Application (2012-2017)
Figure EMEA Naloxone Sales Market Share by Application in 2016
Table EMEA Naloxone Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Naloxone Sales Share by Region (2012-2017)
Figure Sales Market Share of Naloxone by Region (2012-2017)
Figure EMEA Naloxone Sales Market Share in 2016
Table EMEA Naloxone Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Naloxone Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Naloxone by Region (2012-2017)
Figure EMEA Naloxone Revenue Market Share Regions in 2016
Table EMEA Naloxone Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Naloxone Revenue and Growth Rate (2012-2017)
Table Europe Naloxone Sales (K Units) by Type (2012-2017)
Table Europe Naloxone Market Share by Type (2012-2017)
Figure Europe Naloxone Market Share by Type in 2016
Table Europe Naloxone Sales (K Units) by Application (2012-2017)
Table Europe Naloxone Market Share by Application (2012-2017)
Figure Europe Naloxone Market Share by Application in 2016
Table Europe Naloxone Sales (K Units) by Countries (2012-2017)
Table Europe Naloxone Sales Market Share by Countries (2012-2017)
Figure Europe Naloxone Sales Market Share by Countries (2012-2017)
Figure Europe Naloxone Sales Market Share by Countries in 2016
Table Europe Naloxone Revenue (Million USD) by Countries (2012-2017)
Table Europe Naloxone Revenue Market Share by Countries (2012-2017)
Figure Europe Naloxone Revenue Market Share by Countries (2012-2017)
Figure Europe Naloxone Revenue Market Share by Countries in 2016
Figure Germany Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure France Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure UK Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Naloxone Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Naloxone Sales (K Units) by Type (2012-2017)
Table Middle East Naloxone Market Share by Type (2012-2017)
Figure Middle East Naloxone Market Share by Type (2012-2017)
Table Middle East Naloxone Sales (K Units) by Applications (2012-2017)
Table Middle East Naloxone Market Share by Applications (2012-2017)
Figure Middle East Naloxone Sales Market Share by Application in 2016
Table Middle East Naloxone Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Naloxone Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Naloxone Sales Volume Market Share by Countries in 2016
Table Middle East Naloxone Revenue (Million USD) by Countries (2012-2017)
Table Middle East Naloxone Revenue Market Share by Countries (2012-2017)
Figure Middle East Naloxone Revenue Market Share by Countries (2012-2017)
Figure Middle East Naloxone Revenue Market Share by Countries in 2016
Figure Saudi Arabia Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Naloxone Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Naloxone Sales (K Units) by Type (2012-2017)
Table Africa Naloxone Sales Market Share by Type (2012-2017)
Figure Africa Naloxone Sales Market Share by Type (2012-2017)
Figure Africa Naloxone Sales Market Share by Type in 2016
Table Africa Naloxone Sales (K Units) by Application (2012-2017)
Table Africa Naloxone Sales Market Share by Application (2012-2017)
Figure Africa Naloxone Sales Market Share by Application (2012-2017)
Table Africa Naloxone Sales Volume (K Units) by Countries (2012-2017)
Table Africa Naloxone Sales Market Share by Countries (2012-2017)
Figure Africa Naloxone Sales Market Share by Countries (2012-2017)
Figure Africa Naloxone Sales Market Share by Countries in 2016
Table Africa Naloxone Revenue (Million USD) by Countries (2012-2017)
Table Africa Naloxone Revenue Market Share by Countries (2012-2017)
Figure Africa Naloxone Revenue Market Share by Countries (2012-2017)
Figure Africa Naloxone Revenue Market Share by Countries in 2016
Figure South Africa Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Naloxone Sales (K Units) and Growth Rate (2012-2017)
Table ADAPT Pharma Naloxone Basic Information List
Table ADAPT Pharma Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ADAPT Pharma Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure ADAPT Pharma Naloxone Sales Market Share in EMEA (2012-2017)
Figure ADAPT Pharma Naloxone Revenue Market Share in EMEA (2012-2017)
Table Amphastar Pharmaceuticals Naloxone Basic Information List
Table Amphastar Pharmaceuticals Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amphastar Pharmaceuticals Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Amphastar Pharmaceuticals Naloxone Sales Market Share in EMEA (2012-2017)
Figure Amphastar Pharmaceuticals Naloxone Revenue Market Share in EMEA (2012-2017)
Table Pfizer Naloxone Basic Information List
Table Pfizer Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Naloxone Sales Market Share in EMEA (2012-2017)
Figure Pfizer Naloxone Revenue Market Share in EMEA (2012-2017)
Table kaleo Naloxone Basic Information List
Table kaleo Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure kaleo Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure kaleo Naloxone Sales Market Share in EMEA (2012-2017)
Figure kaleo Naloxone Revenue Market Share in EMEA (2012-2017)
Table Sandoz Naloxone Basic Information List
Table Sandoz Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sandoz Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Sandoz Naloxone Sales Market Share in EMEA (2012-2017)
Figure Sandoz Naloxone Revenue Market Share in EMEA (2012-2017)
Table Amneal Pharmaceuticals Naloxone Basic Information List
Table Amneal Pharmaceuticals Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amneal Pharmaceuticals Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Amneal Pharmaceuticals Naloxone Sales Market Share in EMEA (2012-2017)
Figure Amneal Pharmaceuticals Naloxone Revenue Market Share in EMEA (2012-2017)
Table West Ward Pharmaceuticals Naloxone Basic Information List
Table West Ward Pharmaceuticals Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure West Ward Pharmaceuticals Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure West Ward Pharmaceuticals Naloxone Sales Market Share in EMEA (2012-2017)
Figure West Ward Pharmaceuticals Naloxone Revenue Market Share in EMEA (2012-2017)
Table Mylan Naloxone Basic Information List
Table Mylan Naloxone Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Naloxone Sales (K Units) and Growth Rate (2012-2017)
Figure Mylan Naloxone Sales Market Share in EMEA (2012-2017)
Figure Mylan Naloxone Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Naloxone
Figure Manufacturing Process Analysis of Naloxone
Figure Naloxone Industrial Chain Analysis
Table Raw Materials Sources of Naloxone Major Manufacturers in 2016
Table Major Buyers of Naloxone
Table Distributors/Traders List
Figure EMEA Naloxone Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Naloxone Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Naloxone Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Naloxone Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Naloxone Sales Market Share Forecast by Region (2017-2022)
Table EMEA Naloxone Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Naloxone Revenue Market Share Forecast by Region (2017-2022)
Table Europe Naloxone Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Naloxone Sales Market Share Forecast by Countries (2017-2022)
Table Europe Naloxone Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Naloxone Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Naloxone Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Naloxone Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Naloxone Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Naloxone Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Naloxone Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Naloxone Sales Market Share Forecast by Countries (2017-2022)
Table Africa Naloxone Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Naloxone Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Naloxone Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Naloxone Sales Market Share Forecast by Type (2017-2022)
Table EMEA Naloxone Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Naloxone Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources